Angelini Industries

Angelini Ventures-the Angelini Industries Group's corporate venture capital firm-takes on the role of co-lead in two strategic financing rounds, Neumirna Therapeutics and Nobi Smart Lights. These operations represent not only a confirmation of the company's ability to identify high-potential opportunities, but also testify its growth as an influential player in the industry.

Mental health is a fundamental pillar of individual and collective well-being, as well as an essential element in a country's socioeconomic growth. An effective system of prevention, diagnosis and treatment of mental illness not only improves the quality of life of citizens, but also contributes to the productivity and sustainability of the healthcare system and the labor market. The findings of the report "Mental Health as an Engine of Italy's Socioeconomic Growth", produced by Angelini Pharma in partnership with The European House - Ambrosetti highlight the importance of an integrated approach to addressing mental health challenges.

The participation of Angelini Technologies-Fameccanica in the exhibition "Italy of Patents. Successful Inventions and Innovations" is a concrete example of how technology and sustainability can converge to meet today’s challenges. Solutions such as the S15 platform and the Greenpackt® project testify to the company's commitment to redefining standards of excellence through the application of advanced technologies and production models that reduce environmental impact and promote a more sustainable future.

Written by Agnese Cattaneo, Chief Medical Officer, Angelini Pharma

Angelini Industries' commitment to generating positive impacts on people, communities, ecosystems, and the planet, in the Letter to Stakeholders that opens the 2023 Sustainability Report. By Thea Paola Angelini, Executive Vice Chairman, and Sergio Marullo di Condojanni, CEO.